Data availability
All data generated or analyzed during this study are included in this published article.
Change history
26 February 2021
A Correction to this paper has been published: https://doi.org/10.1007/s12026-021-09181-9
Abbreviations
- ANA:
-
anti-nuclear antibodies
- Anti-SSA:
-
anti-sicca syndrome A
- Anti-SSB:
-
anti-sicca syndrome A
- B10+:
-
IL-10-producing B cells
- B10neg:
-
IL-10 non-producing B cells
- BFA:
-
Brefeldin A
- ESSDAI:
-
Eular Sjögren Syndrome Disease Activity Index
- PBMCs:
-
peripheral blood mononuclear cells
- PMA:
-
Phorbol 12-myristate 13-acetate
- pSS:
-
primary Sjögren syndrome
- RA:
-
rheumatoid arthritis
- RF:
-
rheumatoid factor
- Th1:
-
T helper 1
- TNFα T cells:
-
TNFα-producing T cells
- Tregs:
-
regulatory T cells
References
Mariette X, Criswell LA. Primary Sjögren’s syndrome. N Engl J Med. 2018;378(10):931–9.
Sheldon J. Laboratory testing in autoimmune rheumatic diseases. Best Pract Res Clin Rheumatol. 2004;18(3):249–69.
Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol. 2002;3(10):944–50.
Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med. 2003;197(4):489–501.
Carter NA, Vasconcellos R, Rosser EC, Tulone C, Muñoz-Suano A, Kamanaka M, et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol. 2011;186(10):5569–79.
Daien CI, Gailhac S, Mura T, Audo R, Combe B, Hahne M, et al. Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activity. Arthritis Rheumatol (Hoboken, NJ). 2014;66(8):2037–46.
Blair PA, Noreña LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity. 2010;32(1):129–40.
Flores-Borja F, Bosma A, Ng D, Reddy V, Ehrenstein MR, Isenberg DA, et al. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med. 2013;5(173):173ra23.
Simon Q, Pers J-O, Cornec D, Le Pottier L, Mageed RA, Hillion S. In-depth characterization of CD24(high)CD38(high) transitional human B cells reveals different regulatory profiles. J Allergy Clin Immunol. 2015.
Miyagaki T, Fujimoto M, Sato S. Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research. Int Immunol. 2015;27(10):495–504.
Furuzawa-Carballeda J, Hernández-Molina G, Lima G, Rivera-Vicencio Y, Férez-Blando K, Llorente L. Peripheral regulatory cells immunophenotyping in primary Sjögren’s syndrome: a cross-sectional study. Arthritis Res Ther. 2013;15(3):R68.
Lin W, Cerny D, Chua E, Duan K, Yi JTJ, Shadan NB, et al. Human regulatory B cells combine phenotypic and genetic hallmarks with a distinct differentiation fate. J Immunol. 2014;193(5):2258–66.
Papp G, Gyimesi E, Szabó K, Zöld É, Zeher M. Increased IL-21 expression induces granzyme B in peripheral CD5(+) B Cells as a potential counter-regulatory effect in primary Sjögren’s syndrome. Mediat Inflamm. 2016;2016:4328372.
Lin X, Wang X, Xiao F, Ma K, Liu L, Wang X, et al. IL-10-producing regulatory B cells restrain the T follicular helper cell response in primary Sjögren’s syndrome. Cell Mol Immunol. 2019;16(12):921–31.
Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 2011;117(2):530–41.
Szabó K, Papp G, Szántó A, Tarr T, Zeher M. A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren’s syndrome and systemic lupus erythematosus. Clin Exp Immunol. 2016;183(1):76–89.
Furuzawa-Carballeda J, Sánchez-Guerrero J, Betanzos JL, Enriquez AB, Avila-Casado C, Llorente L, et al. Differential cytokine expression and regulatory cells in patients with primary and secondary Sjögren’s syndrome. Scand J Immunol. 2014;80(6):432–40.
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554–8.
Mielle J, Audo R, Hahne M, Macia L, Combe B, Morel J, et al. IL-10 producing B cells ability to induce regulatory T cells is maintained in rheumatoid arthritis. Front Immunol. 2018;9:961.
Davies R, Hammenfors D, Bergum B, Jakobsen K, Solheim M, Vogelsang P, et al. Patients with primary Sjögren’s syndrome have alterations in absolute quantities of specific peripheral leucocyte populations. Scand J Immunol. 2017;86(6):491–502.
Acknowledgments
We thank Sumaiya Hoque for English correction of the manuscript and Claire Rempenault for her help in writing the manuscript. We acknowledge the imaging facility MRI, member of the national infrastructure France-BioImaging, supported by the French National Research Agency (ANR-10-INBS-04, “Investments for the future”), and more especially, Myriam Boyer and Sarah Gailhac for the cell sorting.
Funding
We received the financial support of the GCS-MERRI Nimes Montpellier and the AFGS (Association Française des patients atteints de Gougerot Sjögren et syndromes secs).
Author information
Authors and Affiliations
Contributions
J.Mi designed and performed the experiments; collected, analyzed, and interpreted the data; and prepared and wrote the manuscript. A.R designed and performed the experiments; collected, analyzed, and interpreted the data; and wrote the manuscript. A.N. designed, conducted patient enrolment into the study and performed the experiments, interpreted the data, and critically read the manuscript. GV critically read the manuscript and gave scientific advice. P.G, B.C, and J.Mo contributed to patient enrolment into the study and critically read the manuscript. C.D. obtained financial support, designed the experiments, conducted patient enrolment into the study, interpreted the data, and wrote the manuscript. All the authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval and consent to participate
This study has been approved by the Medical Ethics Committee of Nimes hospital, France (CPP_2012-A00592-41).
Consent for publication
Not applicable.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: The first name and last name of the authors in the published version of this article have been exchanged.
Supplementary Information
ESM 1
(PDF 457 kb)
Rights and permissions
About this article
Cite this article
Mielle, J., Nutz, A., Guillpain, P. et al. IL-10-producing regulatory B cells are present and functional in primary Sjögren patients. Immunol Res 69, 107–113 (2021). https://doi.org/10.1007/s12026-021-09171-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12026-021-09171-x